Grifols reported EUR2.07B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Arca Biopharma USD 384M 295M Mar/2025
aTyr Pharma USD 71M 63M Sep/2025
Bio Path USD 1000K 4M Mar/2025
Brainstorm Cell Therapeutics USD 10M 4M Mar/2025
Capricor Therapeutics USD 434M 195M Mar/2025
Cara Therapeutics USD 28M 11M Dec/2024
Esperion Therapeutics USD 475M 410M Mar/2026
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Grifols EUR 6.77B 773M Sep/2025
Infinity Pharmaceuticals USD 19M 5M Jun/2023